SHARE-BASED PAYMENT (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The grant date fair value of the stock options was determined using the Black-Scholes-Merton model with the following assumptions: | | | | | | | Six months ended June 30, 2025 | Exercise price | $ | 3.57 | | Expected terms (years) | 5.94 | Volatility | 109.06 | % | Risk-free interest rate | 4.04 | % | Expected dividend yields | 0.00 | % | Weighted average fair value of options granted | $ | 2.99 | |
|
Schedule of Stock Option Activity Plan |
Stock options activity for the six months ended June 30, 2025 and 2024 was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | Stock options life | | Number of Shares | | Weighted Average Exercise Price (US$) | | Weighted Average Grant Date Fair Value (US$) | | Weighted Average Remaining Contractual Life | Outstanding as of December 31, 2024 | | 32,701,399 | | | 5.80 | | | 4.58 | | | 4.5 | Granted | | 300,000 | | | 3.57 | | | 2.99 | | | | Exercised | | (33,334) | | | 2.08 | | | 1.48 | | | | Forfeited | | (3,947,722) | | | 6.20 | | | 4.85 | | | | Outstanding as of June 30, 2025 | | 29,020,343 | | | 5.72 | | | 4.53 | | | 4.2 | Expected to vest and exercisable as of June 30, 2025 | | 29,020,343 | | | 5.72 | | | 4.53 | | | 4.2 | Exercisable as of June 30, 2025 | | 26,487,010 | | | 6.12 | | | 4.85 | | | 4.0 | | | | | | | | | | Outstanding as of December 31, 2023 | | 32,876,682 | | | 6.01 | | | 4.73 | | | 5.7 | Forfeited | | (1,243,497) | | | 4.22 | | | 2.83 | | | | Outstanding as of June 30, 2024 | | 31,633,185 | | | 6.08 | | | 4.80 | | | 5.2 | Expected to vest and exercisable as of June 30, 2024 | | 31,633,185 | | | 6.08 | | | 4.80 | | | 5.2 | Exercisable as of June 30, 2024 | | 20,922,066 | | | 6.15 | | | 4.88 | | | 5.2 |
|
Schedule Non-vested Shares Activity |
The non-vested RSUs activity for the six months ended June 30, 2025 and 2024 was as follows: | | | | | | | | | | | | | | | | | Number of Non-Vested Shares | | Weighted Average Grant Date Fair Value Per Share (U.S.$) | Outstanding as of December 31, 2024 | | 3,423,305 | | | 1.63 | | Granted | | 1,208,787 | | | 2.78 | | Vested | | (489,143) | | | 2.57 | | Forfeited | | (128,941) | | | 1.81 | | Outstanding as of June 30, 2025 | | 4,014,008 | | | 1.86 | | | | | | | Outstanding as of December 31, 2023 | | 3,598,606 | | | 3.07 | | Granted | | 79,909 | | | 1.40 | | Vested | | (503,505) | | | 2.65 | | Forfeited | | (749,267) | | | 4.33 | | Outstanding as of June 30, 2024 | | 2,425,743 | | | 2.72 | |
|
Schedule of Classification of Stock-based Compensation |
The following summarizes the classification of share-based compensation: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Cost of revenues | $ | 62 | | | $ | 1,481 | | | $ | 124 | | | $ | 2,619 | | General and administrative expenses | 566 | | | 7,633 | | | 1,003 | | | 15,800 | | Research and development expenses | 156 | | | 2,521 | | | 306 | | | 4,298 | | Selling and marketing expenses | 62 | | | 488 | | | 116 | | | 1,271 | | Construction in process | — | | | (17) | | | — | | | 14 | | Total | $ | 846 | | | $ | 12,106 | | | $ | 1,549 | | | $ | 24,002 | |
|